• Contact Us
  • New Tenders
  • Register
  • Login

A.R.V. For Animal use 10 dose Antirabies inactivated tissue culture vaccine for animal use in 10 dose vial

SrilankaTender notice for A.R.V. For Animal use 10 dose Antirabies inactivated tissue culture vaccine for animal use in 10 dose vial. The reference ID of the tender is 77988015 and it is closing on 16 Feb 2023.

Tender Details

  • Country: Sri Lanka
  • Summary: A.R.V. For Animal use 10 dose Antirabies inactivated tissue culture vaccine for animal use in 10 dose vial
  • LKT Ref No: 77988015
  • Deadline: 16 Feb 2023
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: DHS/RP/499/2020
  • Purchaser's Detail:
  • Purchaser : STATE PHARMACEUTICALS CORPORATION OF SRI LANKA
    No.75, Sir Baron Jayathilake Mawatha, Colombo 01, Sri Lanka. Telephone :+94 (0)11 2320356-9, Fax :+94 (0)11 2447118
    Email :chairman@spc.lk

  • Description:
  • A.R.V. For Animal use 10 dose Antirabies inactivated tissue culture vaccine for animal use in 10 dose vial
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
SrilankaTender Features

SrilankaTender Features

Fresh and verified Tenders from Srilanka. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Srilanka in your email inbox.

  Chat with us